ArticleEMBO molecular medicine2021
Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin.
Guilherme Dias de Melo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this paperpooled ittrialcites it